APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Mesalazine Suppositories

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Mesalazine Suppositories Industry Growth and Trends Forecast to 2032

Report ID 174012320127 December 202593 pages

Choose your research edition.

Industry ResearchMesalazine Suppositories Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Mesalazine Suppositories Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Mesalazine Suppositories Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Mesalazine Suppositories Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Mesalazine Suppositories Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Mesalazine Suppositories market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Mesalazine Suppositories is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Mesalazine Suppositories is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Mesalazine Suppositories is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Mesalazine Suppositories include Zambon, Teva Pharmaceutical Industries, Mylan N.V., Salix Pharmaceuticals, Ferring Pharmaceuticals and AbbVie, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Mesalazine Suppositories market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Mesalazine Suppositories market size, estimates, and forecasts are presented in terms of sales volume (Tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Mesalazine Suppositories market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Mesalazine Suppositories.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Mesalazine Suppositories market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Mesalazine Suppositories Market by Company

Zambon

Teva Pharmaceutical Industries

Mylan N.V.

Salix Pharmaceuticals

Ferring Pharmaceuticals

AbbVie

Mesalazine Suppositories Segment by Type

0.25g

0.5g

1g

Mesalazine Suppositories Segment by Application

Hospital

Clinic

Others

Mesalazine Suppositories Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Mesalazine Suppositories market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Mesalazine Suppositories and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Mesalazine Suppositories.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Mesalazine Suppositories manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Mesalazine Suppositories in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 0.25g Table 2. Major Company of 0.5g Table 3. Major Company of 1g Table 4. Global Mesalazine Suppositories Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Mesalazine Suppositories Sales by Type (2021-2026) & (Tons) Table 6. Global Mesalazine Suppositories Sales Market Share in Volume by Type (2021-2026) Table 7. Global Mesalazine Suppositories Sales by Type (2021-2026) & (US$ Million) Table 8. Global Mesalazine Suppositories Sales Market Share in Value by Type (2021-2026) Table 9. Global Mesalazine Suppositories Price by Type (2021-2026) & (US$/Ton) Table 10. Global Mesalazine Suppositories Sales by Type (2027-2032) & (Tons) Table 11. Global Mesalazine Suppositories Sales Market Share in Volume by Type (2027-2032) Table 12. Global Mesalazine Suppositories Sales by Type (2027-2032) & (US$ Million) Table 13. Global Mesalazine Suppositories Sales Market Share in Value by Type (2027-2032) Table 14. Global Mesalazine Suppositories Price by Type (2027-2032) & (US$/Ton) Table 15. North America Mesalazine Suppositories Sales by Type (2021-2026) & (Tons) Table 16. North America Mesalazine Suppositories Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Mesalazine Suppositories Sales by Type (2021-2026) & (Tons) Table 18. Europe Mesalazine Suppositories Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Mesalazine Suppositories Sales by Type (2021-2026) & (Tons) Table 20. Asia-Pacific Mesalazine Suppositories Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Mesalazine Suppositories Sales by Type (2021-2026) & (Tons) Table 22. Latin America Mesalazine Suppositories Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Mesalazine Suppositories Sales by Type (2021-2026) & (Tons) Table 24. Middle East and Africa Mesalazine Suppositories Sales by Type (2021-2026) & (US$ Million) Table 25. Mesalazine Suppositories Industry Trends Table 26. Mesalazine Suppositories Industry Drivers Table 27. Mesalazine Suppositories Industry Opportunities and Challenges Table 28. Mesalazine Suppositories Industry Restraints Table 29. Global Mesalazine Suppositories Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Mesalazine Suppositories Revenue Market Share by Company (2021-2026) Table 31. Global Mesalazine Suppositories Sales by Company (2021-2026) & (Tons) Table 32. Global Mesalazine Suppositories Sales Share by Company (2021-2026) Table 33. Global Mesalazine Suppositories Market Price by Company (2021-2026) & (US$/Ton) Table 34. Global Mesalazine Suppositories Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Mesalazine Suppositories Major Company Production Sites and Headquarters Table 36. Global Mesalazine Suppositories Company, Product Type & Application Table 37. Global Mesalazine Suppositories Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Mesalazine Suppositories by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Mesalazine Suppositories Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Mesalazine Suppositories Sales by Region (2021-2026) & (Tons) Table 42. Global Mesalazine Suppositories Sales Market Share in Volume by Region (2021-2026) Table 43. Global Mesalazine Suppositories Sales by Region (2021-2026) & (US$ Million) Table 44. Global Mesalazine Suppositories Sales Market Share in Value by Region (2021-2026) Table 45. Global Mesalazine Suppositories Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 46. Global Mesalazine Suppositories Sales by Region (2027-2032) & (Tons) Table 47. Global Mesalazine Suppositories Sales Market Share in Volume by Region (2027-2032) Table 48. Global Mesalazine Suppositories Sales by Region (2027-2032) & (US$ Million) Table 49. Global Mesalazine Suppositories Sales Market Share in Value by Region (2027-2032) Table 50. Global Mesalazine Suppositories Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2027-2032) Table 51. Global Mesalazine Suppositories Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Mesalazine Suppositories Sales by Application (2021-2026) & (Tons) Table 53. Global Mesalazine Suppositories Sales Market Share in Volume by Application (2021-2026) Table 54. Global Mesalazine Suppositories Sales by Application (2021-2026) & (US$ Million) Table 55. Global Mesalazine Suppositories Sales Market Share in Value by Application (2021-2026) Table 56. Global Mesalazine Suppositories Price by Application (2021-2026) & (US$/Ton) Table 57. Global Mesalazine Suppositories Sales by Application (2027-2032) & (Tons) Table 58. Global Mesalazine Suppositories Sales Market Share in Volume by Application (2027-2032) Table 59. Global Mesalazine Suppositories Sales by Application (2027-2032) & (US$ Million) Table 60. Global Mesalazine Suppositories Sales Market Share in Value by Application (2027-2032) Table 61. Global Mesalazine Suppositories Price by Application (2027-2032) & (US$/Ton) Table 62. North America Mesalazine Suppositories Sales by Application (2021-2026) & (Tons) Table 63. North America Mesalazine Suppositories Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Mesalazine Suppositories Sales by Application (2021-2026) & (Tons) Table 65. Europe Mesalazine Suppositories Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Mesalazine Suppositories Sales by Application (2021-2026) & (Tons) Table 67. Asia-Pacific Mesalazine Suppositories Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Mesalazine Suppositories Sales by Application (2021-2026) & (Tons) Table 69. Latin America Mesalazine Suppositories Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Mesalazine Suppositories Sales by Application (2021-2026) & (Tons) Table 71. Middle East and Africa Mesalazine Suppositories Sales by Application (2021-2026) & (US$ Million) Table 72. Zambon Company Information Table 73. Zambon Business Overview Table 74. Zambon Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 75. Zambon Mesalazine Suppositories Product Portfolio Table 76. Zambon Recent Development Table 77. Teva Pharmaceutical Industries Company Information Table 78. Teva Pharmaceutical Industries Business Overview Table 79. Teva Pharmaceutical Industries Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 80. Teva Pharmaceutical Industries Mesalazine Suppositories Product Portfolio Table 81. Teva Pharmaceutical Industries Recent Development Table 82. Mylan N.V. Company Information Table 83. Mylan N.V. Business Overview Table 84. Mylan N.V. Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 85. Mylan N.V. Mesalazine Suppositories Product Portfolio Table 86. Mylan N.V. Recent Development Table 87. Salix Pharmaceuticals Company Information Table 88. Salix Pharmaceuticals Business Overview Table 89. Salix Pharmaceuticals Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 90. Salix Pharmaceuticals Mesalazine Suppositories Product Portfolio Table 91. Salix Pharmaceuticals Recent Development Table 92. Ferring Pharmaceuticals Company Information Table 93. Ferring Pharmaceuticals Business Overview Table 94. Ferring Pharmaceuticals Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 95. Ferring Pharmaceuticals Mesalazine Suppositories Product Portfolio Table 96. Ferring Pharmaceuticals Recent Development Table 97. AbbVie Company Information Table 98. AbbVie Business Overview Table 99. AbbVie Mesalazine Suppositories Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 100. AbbVie Mesalazine Suppositories Product Portfolio Table 101. AbbVie Recent Development Table 102. North America Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 103. North America Mesalazine Suppositories Sales by Country (2021-2026) & (Tons) Table 104. North America Mesalazine Suppositories Sales Market Share by Country (2021-2026) Table 105. North America Mesalazine Suppositories Sales Forecast by Country (2027-2032) & (Tons) Table 106. North America Mesalazine Suppositories Sales Market Share Forecast by Country (2027-2032) Table 107. North America Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. North America Mesalazine Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 109. North America Mesalazine Suppositories Market Share by Country (2021-2026) Table 110. North America Mesalazine Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. North America Mesalazine Suppositories Market Share Forecast by Country (2027-2032) Table 112. Europe Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 113. Europe Mesalazine Suppositories Sales by Country (2021-2026) & (Tons) Table 114. Europe Mesalazine Suppositories Sales Market Share by Country (2021-2026) Table 115. Europe Mesalazine Suppositories Sales Forecast by Country (2027-2032) & (Tons) Table 116. Europe Mesalazine Suppositories Sales Market Share Forecast by Country (2027-2032) Table 117. Europe Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Europe Mesalazine Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 119. Europe Mesalazine Suppositories Market Share by Country (2021-2026) Table 120. Europe Mesalazine Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Europe Mesalazine Suppositories Market Share Forecast by Country (2027-2032) Table 122. Asia-Pacific Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 123. Asia-Pacific Mesalazine Suppositories Sales by Country (2021-2026) & (Tons) Table 124. Asia-Pacific Mesalazine Suppositories Sales Market Share by Country (2021-2026) Table 125. Asia-Pacific Mesalazine Suppositories Sales Forecast by Country (2027-2032) & (Tons) Table 126. Asia-Pacific Mesalazine Suppositories Sales Market Share Forecast by Country (2027-2032) Table 127. Asia-Pacific Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Asia-Pacific Mesalazine Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 129. Asia-Pacific Mesalazine Suppositories Market Share by Country (2021-2026) Table 130. Asia-Pacific Mesalazine Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Asia-Pacific Mesalazine Suppositories Market Share Forecast by Country (2027-2032) Table 132. Latin America Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 133. Latin America Mesalazine Suppositories Sales by Country (2021-2026) & (Tons) Table 134. Latin America Mesalazine Suppositories Sales Market Share by Country (2021-2026) Table 135. Latin America Mesalazine Suppositories Sales Forecast by Country (2027-2032) & (Tons) Table 136. Latin America Mesalazine Suppositories Sales Market Share Forecast by Country (2027-2032) Table 137. Latin America Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Latin America Mesalazine Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 139. Latin America Mesalazine Suppositories Market Share by Country (2021-2026) Table 140. Latin America Mesalazine Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Latin America Mesalazine Suppositories Market Share Forecast by Country (2027-2032) Table 142. Middle East and Africa Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (Tons): 2021 VS 2025 VS 2032 Table 143. Middle East and Africa Mesalazine Suppositories Sales by Country (2021-2026) & (Tons) Table 144. Middle East and Africa Mesalazine Suppositories Sales Market Share by Country (2021-2026) Table 145. Middle East and Africa Mesalazine Suppositories Sales Forecast by Country (2027-2032) & (Tons) Table 146. Middle East and Africa Mesalazine Suppositories Sales Market Share Forecast by Country (2027-2032) Table 147. Middle East and Africa Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Middle East and Africa Mesalazine Suppositories Market Size by Country (2021-2026) & (US$ Million) Table 149. Middle East and Africa Mesalazine Suppositories Market Share by Country (2021-2026) Table 150. Middle East and Africa Mesalazine Suppositories Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Middle East and Africa Mesalazine Suppositories Market Share Forecast by Country (2027-2032) Table 152. Key Raw Materials Table 153. Raw Materials Key Suppliers Table 154. Mesalazine Suppositories Distributors List Table 155. Mesalazine Suppositories Customers List Table 156. Research Programs/Design for This Report Table 157. Authors List of This Report Table 158. Secondary Sources Table 159. Primary Sources List of Figures Figure 1. Mesalazine Suppositories Image Figure 2. Global Mesalazine Suppositories Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Mesalazine Suppositories Market Size (2021-2032) & (US$ Million) Figure 4. Global Mesalazine Suppositories Sales (2021-2032) & (Tons) Figure 5. 0.25g Image Figure 6. Global 0.25g Sales YoY Growth (2021-2032) & (Tons) Figure 7. 0.5g Image Figure 8. Global 0.5g Sales YoY Growth (2021-2032) & (Tons) Figure 9. 1g Image Figure 10. Global 1g Sales YoY Growth (2021-2032) & (Tons) Figure 11. Global Mesalazine Suppositories Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Mesalazine Suppositories Market Share by Type 2025 VS 2032 Figure 13. North America Mesalazine Suppositories Sales Market Share in Volume by Type in 2025 Figure 14. North America Mesalazine Suppositories Sales Market Share in Value by Type in 2025 Figure 15. Europe Mesalazine Suppositories Sales Market Share in Volume by Type in 2025 Figure 16. Europe Mesalazine Suppositories Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Mesalazine Suppositories Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Mesalazine Suppositories Sales Market Share in Value by Type in 2025 Figure 19. Latin America Mesalazine Suppositories Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Mesalazine Suppositories Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Mesalazine Suppositories Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Mesalazine Suppositories Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Mesalazine Suppositories Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (Tons) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (Tons) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (Tons) Figure 31. Global Mesalazine Suppositories Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Mesalazine Suppositories Market Share by Application 2025 VS 2032 Figure 33. North America Mesalazine Suppositories Sales Market Share in Volume by Application in 2025 Figure 34. North America Mesalazine Suppositories Sales Market Share in Value by Application in 2025 Figure 35. Europe Mesalazine Suppositories Sales Market Share in Volume by Application in 2025 Figure 36. Europe Mesalazine Suppositories Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Mesalazine Suppositories Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Mesalazine Suppositories Sales Market Share in Value by Application in 2025 Figure 39. Latin America Mesalazine Suppositories Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Mesalazine Suppositories Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Mesalazine Suppositories Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Mesalazine Suppositories Sales Market Share in Value by Application in 2025 Figure 43. North America Mesalazine Suppositories Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 44. North America Mesalazine Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Mesalazine Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Mesalazine Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Mesalazine Suppositories Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 48. Europe Mesalazine Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Mesalazine Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Mesalazine Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Mesalazine Suppositories Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 52. Asia-Pacific Mesalazine Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Mesalazine Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Mesalazine Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Mesalazine Suppositories Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 56. Latin America Mesalazine Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Mesalazine Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Mesalazine Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Mesalazine Suppositories Sales by Country: 2021 VS 2025 VS 2032 (Tons) Figure 60. Middle East and Africa Mesalazine Suppositories Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Mesalazine Suppositories Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Mesalazine Suppositories Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Mesalazine Suppositories Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Mesalazine Suppositories Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 0.25g
  • 0.5g
  • 1g
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Zambon
  • Teva Pharmaceutical Industries
  • Mylan N.V.
  • Salix Pharmaceuticals
  • Ferring Pharmaceuticals
  • AbbVie

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Mesalazine Suppositories Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Mesalazine Suppositories Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Mesalazine Suppositories Market by Type
  6. 1.3.1 0.25g
  7. 1.3.2 0.5g
  8. 1.3.3 1g
  9. 1.4 Global Mesalazine Suppositories Market Size by Type
  10. 1.4.1 Global Mesalazine Suppositories Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Mesalazine Suppositories Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Mesalazine Suppositories Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Mesalazine Suppositories Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Mesalazine Suppositories Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Mesalazine Suppositories Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Mesalazine Suppositories Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Mesalazine Suppositories Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Mesalazine Suppositories Industry Trends
  2. 2.2 Mesalazine Suppositories Industry Drivers
  3. 2.3 Mesalazine Suppositories Industry Opportunities and Challenges
  4. 2.4 Mesalazine Suppositories Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Mesalazine Suppositories Revenue (2021-2026)
  2. 3.2 Global Top Players by Mesalazine Suppositories Sales (2021-2026)
  3. 3.3 Global Top Players by Mesalazine Suppositories Price (2021-2026)
  4. 3.4 Global Mesalazine Suppositories Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Mesalazine Suppositories Major Company Production Sites & Headquarters
  6. 3.6 Global Mesalazine Suppositories Company, Product Type & Application
  7. 3.7 Global Mesalazine Suppositories Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Mesalazine Suppositories Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Mesalazine Suppositories Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Mesalazine Suppositories Tier 1, Tier 2, and Tier 3
4 Mesalazine Suppositories Regional Status and Outlook
  1. 4.1 Global Mesalazine Suppositories Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Mesalazine Suppositories Historic Market Size by Region
  3. 4.2.1 Global Mesalazine Suppositories Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Mesalazine Suppositories Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Mesalazine Suppositories Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Mesalazine Suppositories Forecasted Market Size by Region
  7. 4.3.1 Global Mesalazine Suppositories Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Mesalazine Suppositories Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Mesalazine Suppositories Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Mesalazine Suppositories by Application
  1. 5.1 Mesalazine Suppositories Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Mesalazine Suppositories Market Size by Application
  6. 5.2.1 Global Mesalazine Suppositories Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Mesalazine Suppositories Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Mesalazine Suppositories Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Mesalazine Suppositories Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Mesalazine Suppositories Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Mesalazine Suppositories Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Mesalazine Suppositories Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Mesalazine Suppositories Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Zambon
  2. 6.1.1 Zambon Company Information
  3. 6.1.2 Zambon Business Overview
  4. 6.1.3 Zambon Mesalazine Suppositories Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Zambon Mesalazine Suppositories Product Portfolio
  6. 6.1.5 Zambon Recent Developments
  7. 6.2 Teva Pharmaceutical Industries
  8. 6.2.1 Teva Pharmaceutical Industries Company Information
  9. 6.2.2 Teva Pharmaceutical Industries Business Overview
  10. 6.2.3 Teva Pharmaceutical Industries Mesalazine Suppositories Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Teva Pharmaceutical Industries Mesalazine Suppositories Product Portfolio
  12. 6.2.5 Teva Pharmaceutical Industries Recent Developments
  13. 6.3 Mylan N.V.
  14. 6.3.1 Mylan N.V. Company Information
  15. 6.3.2 Mylan N.V. Business Overview
  16. 6.3.3 Mylan N.V. Mesalazine Suppositories Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Mylan N.V. Mesalazine Suppositories Product Portfolio
  18. 6.3.5 Mylan N.V. Recent Developments
  19. 6.4 Salix Pharmaceuticals
  20. 6.4.1 Salix Pharmaceuticals Company Information
  21. 6.4.2 Salix Pharmaceuticals Business Overview
  22. 6.4.3 Salix Pharmaceuticals Mesalazine Suppositories Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Salix Pharmaceuticals Mesalazine Suppositories Product Portfolio
  24. 6.4.5 Salix Pharmaceuticals Recent Developments
  25. 6.5 Ferring Pharmaceuticals
  26. 6.5.1 Ferring Pharmaceuticals Company Information
  27. 6.5.2 Ferring Pharmaceuticals Business Overview
  28. 6.5.3 Ferring Pharmaceuticals Mesalazine Suppositories Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Ferring Pharmaceuticals Mesalazine Suppositories Product Portfolio
  30. 6.5.5 Ferring Pharmaceuticals Recent Developments
  31. 6.6 AbbVie
  32. 6.6.1 AbbVie Company Information
  33. 6.6.2 AbbVie Business Overview
  34. 6.6.3 AbbVie Mesalazine Suppositories Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 AbbVie Mesalazine Suppositories Product Portfolio
  36. 6.6.5 AbbVie Recent Developments
7 North America by Country
  1. 7.1 North America Mesalazine Suppositories Sales by Country
  2. 7.1.1 North America Mesalazine Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Mesalazine Suppositories Sales by Country (2021-2026)
  4. 7.1.3 North America Mesalazine Suppositories Sales Forecast by Country (2027-2032)
  5. 7.2 North America Mesalazine Suppositories Market Size by Country
  6. 7.2.1 North America Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Mesalazine Suppositories Market Size by Country (2021-2026)
  8. 7.2.3 North America Mesalazine Suppositories Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Mesalazine Suppositories Sales by Country
  2. 8.1.1 Europe Mesalazine Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Mesalazine Suppositories Sales by Country (2021-2026)
  4. 8.1.3 Europe Mesalazine Suppositories Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Mesalazine Suppositories Market Size by Country
  6. 8.2.1 Europe Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Mesalazine Suppositories Market Size by Country (2021-2026)
  8. 8.2.3 Europe Mesalazine Suppositories Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Mesalazine Suppositories Sales by Country
  2. 9.1.1 Asia-Pacific Mesalazine Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Mesalazine Suppositories Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Mesalazine Suppositories Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Mesalazine Suppositories Market Size by Country
  6. 9.2.1 Asia-Pacific Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Mesalazine Suppositories Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Mesalazine Suppositories Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Mesalazine Suppositories Sales by Country
  2. 10.1.1 South America Mesalazine Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Mesalazine Suppositories Sales by Country (2021-2026)
  4. 10.1.3 South America Mesalazine Suppositories Sales Forecast by Country (2027-2032)
  5. 10.2 South America Mesalazine Suppositories Market Size by Country
  6. 10.2.1 South America Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Mesalazine Suppositories Market Size by Country (2021-2026)
  8. 10.2.3 South America Mesalazine Suppositories Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Mesalazine Suppositories Sales by Country
  2. 11.1.1 Middle East and Africa Mesalazine Suppositories Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Mesalazine Suppositories Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Mesalazine Suppositories Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Mesalazine Suppositories Market Size by Country
  6. 11.2.1 Middle East and Africa Mesalazine Suppositories Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Mesalazine Suppositories Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Mesalazine Suppositories Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Mesalazine Suppositories Value Chain Analysis
  2. 12.1.1 Mesalazine Suppositories Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Mesalazine Suppositories Production Mode & Process
  7. 12.2 Mesalazine Suppositories Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Mesalazine Suppositories Distributors
  10. 12.2.3 Mesalazine Suppositories Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst